LEGN
$19.06
Revenue | $307.64Mn |
Net Profits | $-31.03Mn |
Net Profit Margins | -10.09% |
Legend Biotech Corp’s revenue jumped 64.93% since last year same period to $307.64Mn in the Q4 2025. On a quarterly growth basis, Legend Biotech Corp has generated 12.96% jump in its revenue since last 3-months.
Legend Biotech Corp’s net profit fell -218.08% since last year same period to $-31.03Mn in the Q4 2025. On a quarterly growth basis, Legend Biotech Corp has generated 21.8% jump in its net profits since last 3-months.
Legend Biotech Corp’s net profit margin fell -171.59% since last year same period to -10.09% in the Q4 2025. On a quarterly growth basis, Legend Biotech Corp has generated 30.78% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.01 |
EPS Estimate Current Year | 0.01 |
Legend Biotech Corp’s earning per share (EPS) estimates for the current quarter stand at 0.01 - a 57.45% jump from last quarter’s estimates.
Legend Biotech Corp’s earning per share (EPS) estimates for the current year stand at 0.01.
Earning Per Share (EPS) | 0 |
Legend Biotech Corp’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Legend Biotech Corp has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-19 | 0.01 | 0 | -100% |